Amneal Pharmaceuticals Inc (AMRX)

개요 뉴스 가격 이력 옵션 체인 토론 예측

Relative Volume:

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Amneal Pharmaceuticals Inc

Healthcare (1164)

908-947-3120

400 Crossing Boulevard, 3rd Floor, Bridgewater

@amnealpharma

최신 SEC 제출 서류

AMRX's Discussions on Twitter

AMRX을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
AMRX Amneal Pharmaceuticals Inc	9.265	2.83B	2.68B	-184.45M	229.23M	-0.6805
ZTS Zoetis Inc	153.09	66.38B	9.39B	2.62B	2.22B	5.81
TAK Takeda Pharmaceutical Co Adr	14.81	46.20B	29.96B	957.25M	4.77B	0.304
HLN Haleon Plc Adr	9.725	42.99B	14.26B	1.98B	2.47B	0.4347
TEVA Teva Pharmaceutical Industries Ltd Adr	17.48	19.04B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	309.17	13.63B	2.99B	1.21B	1.13B	25.06

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-06-06	개시	Goldman	Buy
2025-02-24	업그레이드	JP Morgan	Neutral → Overweight
2024-09-06	업그레이드	JP Morgan	Underweight → Neutral
2021-04-07	재개	RBC Capital Mkts	Sector Perform
2021-03-08	업그레이드	Goldman	Sell → Buy
2020-12-14	업그레이드	Barclays	Equal Weight → Overweight
2020-12-14	업그레이드	Guggenheim	Neutral → Buy
2020-07-27	개시	Goldman	Sell
2020-05-12	업그레이드	Guggenheim	Sell → Neutral
2019-12-12	다운그레이드	Raymond James	Outperform → Mkt Perform
2019-11-12	다운그레이드	JP Morgan	Neutral → Underweight
2019-11-07	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2019-07-22	업그레이드	SVB Leerink	Mkt Perform → Outperform
2019-07-11	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2019-07-08	업그레이드	Piper Jaffray	Neutral → Overweight
2019-06-11	개시	Barclays	Equal Weight
2019-05-21	업그레이드	Raymond James	Mkt Perform → Strong Buy
2019-03-20	개시	SunTrust	Buy
2019-03-08	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2018-12-14	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2018-10-16	다운그레이드	SunTrust	Buy → Hold
2018-08-13	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2018-07-23	개시	Morgan Stanley	Overweight
2018-06-22	개시	B. Riley FBR, Inc.	Buy

Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스

Amneal Pharmaceuticals Inc (AMRX) 재무 분석

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

AMRX을(를) 다른 주식과 비교

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스

Avantor, Viatris, and Amneal Stocks Trade Up, What You Need To Know - TradingView

Amneal Will End Sale of Calcium-Drip Copies in Patent-Suit Pact - Bloomberg Law News

Amneal Pharmaceuticals Insider Sold Shares Worth $302,596, According to a Recent SEC Filing - MarketScreener

Here's Why Momentum in Amneal (AMRX) Should Keep going - Yahoo Finance

Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know - TradingView

Is Amneal Pharmaceuticals Inc. forming a bullish divergenceGuaranteed Profit Setup Watchlist - newsyoung.net

Truist Financial Maintains a Buy on Amneal Pharmaceuticals (AMRX) With an $8 PT - MSN

Brown Rudnick Represents Amneal Pharmaceuticals LLC in a $2.1 Billion Term Loan Credit Facility - Brown Rudnick

‘Made-In-America’ Amneal Does Not Fear Trump’s Proposed ‘Chaotic’ Triple-Digit Tariffs On Drugs - insights.citeline.com

Published on: 2025-08-11 02:04:05 - metal.it

Amneal raises 2025 guidance and targets $300M–$500M peak CREXONT sales as new launches accelerate - MSN

Published on: 2025-08-10 19:02:24 - metal.it

Earnings Beat: Amneal Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - ca.finance.yahoo.com

Amneal 2025 Q2 Earnings Strong Performance as Net Income Surges 112% - AInvest

Amneal (AMRX) Q2 EPS Jumps 56% - AOL.com

Results: Amneal Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st

Amneal Pharma Reports Strong Q2 2025 Results - The Globe and Mail

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Q2 2025 Earnings Call Transcript - Insider Monkey

Amneal Pharmaceuticals Reports Strong Q2 2025 Results - The Globe and Mail

Amneal Pharmaceuticals Q2 2025 Earnings: EPS Beats Estimates, Revenue Falls Short - AInvest

Amneal: Q2 Earnings Snapshot - New Haven Register

Amneal Pharmaceuticals Inc (AMRX) Q2 2025 Earnings Call Highlights: Strong Growth and Raised ... By GuruFocus - Investing.com Canada

Amneal Pharma’s Optimistic Q2 Earnings Call Highlights - TipRanks

Amneal Pharmaceuticals' 2025Q2 Earnings Call: Key Contradictions on RYTARY, CREXONT, and Margin Strategies - AInvest

AMNEAL PHARMACEUTICALS Q2 2025 Earnings Call Transcript - MarketBeat

Earnings call transcript: Amneal Pharma Q2 2025 EPS beats forecast - Investing.com

Earnings call transcript: Amneal Pharma Q2 2025 EPS beats forecast By Investing.com - Investing.com Canada

Amneal Pharmaceuticals Stock Rises Amid Growth Signals - TipRanks

Amneal Pharmaceuticals shares rise 5.53% intraday after revising earnings guidance and raising fiscal 2025 outlook. - AInvest

Transcript : Amneal Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener

Amneal Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Amneal (AMRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Amneal Raises Outlook Even As Revenue Falls Short - Finimize

Knight Therapeutics Submits CREXONT Marketing Authorization Application in Mexico - AInvest

Amneal Pharmaceuticals Lifts Annual Earnings Outlook As Q2 Net Income Surges; Pre-Market Stock Up - Nasdaq

Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates - Yahoo Finance

Amneal Pharmaceuticals Surpasses Q2 Earnings ExpectationsNews and Statistics - IndexBox

Amneal Pharmaceuticals, Inc. Revises Earnings Guidance for the Year Ending December 31, 2025 - MarketScreener

Amneal Pharma A earnings beat by $0.08, revenue fell short of estimates - Investing.com Canada

Amneal Pharmaceuticals beats Q2 estimates, raises full-year outlook - Investing.com

Amneal (NASDAQ:AMRX) Misses Q2 Sales Targets - Yahoo Finance

Earnings Flash (AMRX) Amneal Pharmaceuticals, Inc. Reports Q2 Revenue $724.5M, vs. FactSet Est of $744.6M - MarketScreener

Amneal Pharmaceuticals Reports Strong Q2 2025 Results and Raises Full Year Guidance Following Successful Debt Refinancing - Quiver Quantitative

Amneal Reports Second Quarter 2025 Financial Results - GlobeNewswire

Amneal Pharmaceuticals' Q2 revenue misses estimates - MarketScreener

Amneal Pharmaceuticals Set to Announce Earnings Amid Market ChallengesNews and Statistics - IndexBox

Is There Enough Volume to Lift Amneal Pharmaceuticals Inc.Capital Preservation Forecast Insight Strategy - beatles.ru

Amneal Earnings: What To Look For From AMRX - Yahoo Finance

How does Amneal Pharmaceuticals Inc. compare to its industry peersRapid growth opportunities - Jammu Links News

How many analysts rate Amneal Pharmaceuticals Inc. as a “Buy”Consistent triple returns - Jammu Links News

What is Amneal Pharmaceuticals Inc. company’s growth strategyAccelerated profit realization - Jammu Links News

Amneal Pharmaceuticals Inc (AMRX) 재무 분석

매출

순이익

현금흐름

주당 순 이익

AMRX과 유사한 종목